Percutaneous tricuspid valve leaflet repair is an emerging treatment option for severe tricuspid regurgitation (TR). Recent studies demonstrated the usefulness and feasibility of the lately introduced ...

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

The study found that early intervention led to an 80% reduction in heart failure hospitalisations one year after treatment.

TriCares today shared results from a first-in-human trial supporting its Topaz transcatheter tricuspid valve replacement ...

Once again, data are suggesting that operators should move cautiously in bicuspid anatomy and think about surgery first.

Data from the first-in-human study of Tricares SAS Topaz transcatheter tricuspid valve replacement (TTVR) system, showed it significantly reduced tricuspid regurgitation (TR) in patients treated with ...

Baptist Hospital now offers the latest innovation in treating tricuspid regurgitation or TR — it’s called TriClip. TR is a ...

As in the SMART trial, early hemodynamic differences have yet to result in a clinical impact—but it may just be a matter of ...